Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele
Apr 2, 2020
5:04
Episode Description
Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD
Proudly Supported by
